NAV facilities and subscription lines

Fund-level financing comes in two forms: subscription lines that borrow against your LPs’ unfunded commitments, and NAV facilities that borrow against your portfolio’s value. They serve different purposes and carry different risks. For fund managers, this topic covers when to use each, how to structure, and what to negotiate. For LPs, it explains how these facilities affect your exposure and returns.

Subscription lines: mechanics and use cases

What subscription lines do

A subscription line lets your fund borrow against unfunded LP commitments. The bank takes a security interest in your right to call capital from LPs. You draw on the facility to fund investments, then repay when you actually call the capital.

The typical use case: bridging the 30-90 day gap between when you need to wire money for an investment and when LP funds arrive.

The lender’s credit decision centers on your LP base, not your investments. Banks underwrite the creditworthiness of your LPs, set concentration limits (typically no single LP above 10-15%), and verify commitment letters. A fund with pension funds and endowments gets better terms than one with high-net-worth individuals and family offices.

Why funds use subscription lines:

Operational convenience. Fewer, larger capital calls instead of constant small ones
Cash management. Fund investments immediately without waiting 10-30 days for LP wires
IRR enhancement. Delaying capital calls reduces the denominator and increases measured IRR
Smoother LP experience. Predictable quarterly call schedule rather than ad hoc requests

Typical terms and pricing

Term	Typical Range	Notes
Facility size	15-35% of commitments	Higher increases refinancing risk
Advance rate	80-95% of eligible commitments	LP quality drives this
Pricing	SOFR + 150-275bps	Cheaper for institutional LP base
Commitment fee	25-50bps on undrawn	Incentivizes right-sizing
Tenor	1-3 years	Usually co-terminous with investment period

Covenants typically include LP concentration limits, borrowing base tests, and coverage ratios. Banks want assurance that if they call their loan, you can call your LPs and repay.

The IRR enhancement effect

Here’s how subscription line usage inflates IRR:

Without a subscription line: You call capital on Day 1 for a $100M investment. The IRR clock starts immediately.

With a subscription line: You draw $100M from the facility on Day 1, then call capital 9 months later to repay. Your LPs measure their IRR from month 9, not Day 1.

The dollar profit is identical. But the measured IRR is higher because you’ve shortened the holding period from the LP’s perspective.

Quantifying the effect:

Industry studies suggest subscription lines boost measured IRR by 200-400 basis points. A fund showing 18% IRR might deliver 15% IRR without the subscription line effect.

Note: Net TVPI (total value to paid-in capital) is unaffected by subscription line timing. If you’re evaluating a fund, TVPI gives you the unvarnished return picture.

What this means for LPs:

Your IRR looks better, but your actual return is the same. Worse, you bear a hidden cost: the fund pays interest on the subscription line (SOFR + 200bps adds up), and that expense flows through to you in fund costs. Some LPs now request IRR reporting both with and without subscription line adjustment.

Subscription line risks

LP concentration risk. If your largest LP defaults on a capital call, the facility may be undersecured. Banks mitigate this with concentration limits, but a major LP default still creates problems.

Facility roll risk. If banks pull or reduce lines during market stress (see 2023 regional bank failures), you may need to call capital quickly or find alternative financing. Funds that relied on a single bank provider learned this lesson the hard way.

Transparency concerns. ILPA guidelines recommend disclosure of subscription line usage, and LP reporting should show adjusted IRR. Funds that obscure subscription line impact erode LP trust and face harder questions during re-ups.

NAV facilities: mechanics and use cases

What NAV facilities do

NAV facilities borrow against your portfolio’s value rather than LP commitments. The lender takes a security interest in your fund assets (equity interests in portfolio companies, cash flows, distributions). You receive an advance against NAV, typically 30-60% depending on asset quality and liquidity.

The lender’s credit decision focuses on your portfolio, not your LPs. Banks underwrite the quality and liquidity of underlying investments, concentration risk, cash flow projections, exit visibility, and GP track record.

Why funds use NAV facilities:

Capital recycling. Reinvest in new opportunities without calling more capital from LPs
Bridge to exit. Borrow against portfolio value while you wait for optimal sale timing
Distribution funding. Return capital to LPs while continuing to hold assets
Follow-on investment. Provide additional capital to portfolio companies without a new capital call
GP liquidity. Sponsor monetization (this one raises LP eyebrows)

Typical terms and pricing

Term	Typical Range	Notes
Facility size	15-50% of portfolio NAV	Higher creates margin-call risk
Advance rate	30-60% of NAV	Liquid assets get higher rates
Pricing	SOFR + 400-700bps	2-3x more expensive than sub lines
Commitment fee	50-150bps on undrawn	Higher than sub lines
Tenor	2-5 years	May extend beyond original fund life

Covenants include NAV maintenance tests, interest coverage ratios, and asset concentration limits. Unlike subscription lines where the collateral is LP creditworthiness, NAV facility collateral is investment performance.

Use case analysis

Good uses for NAV facilities:

Timing bridge. Your best portfolio company has a signed LOI for a sale in 6 months. You borrow against current NAV to fund a new investment, repaying when the sale closes.
Follow-on investment. A portfolio company needs growth capital. Rather than call additional LP capital late in fund life, you borrow against portfolio NAV.
J-curve management. You return capital to LPs to manage their cash flow needs while holding appreciating assets for optimal exit timing.
Rescue financing. A portfolio company needs emergency capital. NAV facility lets you act quickly without LP capital call delays.

Concerning uses for NAV facilities:

Masking weakness. Borrowing to pay distributions when underlying portfolio performance is weak.
GP monetization. Using facility proceeds primarily to benefit the sponsor rather than LPs.
Zombie fund extension. Borrowing against unrealized gains to extend fund life indefinitely, collecting management fees on borrowed capital.
Financial engineering. Using leverage to inflate apparent returns when underlying performance disappoints.

LP concerns with NAV facilities

Hidden leverage. A NAV facility adds leverage to your investment as an LP. If portfolio value declines 30% and the fund has a 50% NAV facility, your equity cushion disappears quickly. This leverage isn’t always disclosed clearly.

Alignment questions:

Does this borrowing serve LP interests or GP interests?
Is the GP collecting management fees on borrowed capital?
Are distributions genuine returns or debt-funded financial engineering?

Documentation protections to seek:

LPA provisions limiting NAV facility usage (size caps, purpose restrictions)
LP consent requirements for certain uses (particularly GP monetization)
Reporting requirements on facility utilization, NAV cushion, and purpose of draws

Provider landscape and selection

Bank providers

Major US banks: JPMorgan, Goldman Sachs, Bank of America, Citi, Wells Fargo Major European banks: HSBC, Barclays, Deutsche Bank, BNP Paribas

Bank approach: Banks treat fund finance as relationship business. They want the cross-sell (LP banking, portfolio company financing, M&A advisory). This means relationship leverage works both ways: good GPs get better terms, but banks also expect broader wallet share.

Regulatory capital requirements affect pricing. Banks prefer institutional LP bases for subscription lines (better risk weights). For NAV facilities, banks are selective and often require syndication for larger facilities.

Typical bank terms:

Subscription lines: SOFR + 150-250bps for top-tier managers
NAV facilities: SOFR + 350-550bps for quality portfolios
Annual relationship review (terms may tighten if relationship shrinks)

Non-bank lenders

Insurance companies have become significant players. Apollo/Athene, Ares, and Blue Owl allocate to fund finance for attractive risk-adjusted yield and diversification. Insurance capital is longer-term; they can hold to maturity and accept different covenant structures.

Specialty fund finance lenders like 17Capital and Pemberton focus exclusively on this market. They fill gaps banks won’t serve: higher leverage, smaller managers, more complex structures. Pricing is higher (SOFR + 500-800bps for NAV facilities) but terms may be more flexible.

Non-bank trade-offs:

Higher headline spread but potentially fewer covenants
More flexibility on structure and collateral
Relationship is more transactional (no cross-sell expectations)
May be more willing to extend through stress

Selection criteria

For fund managers evaluating providers:

All-in cost. Spread plus fees plus ongoing requirements
Flexibility. Advance rate, covenant headroom, extension options
Execution certainty. Can they actually close your deal on time?
Relationship value. LP introductions, portfolio company services, market intelligence
Stress behavior. How did they treat clients in 2020? 2023?

Syndicated vs. bilateral:

Bilateral (single lender): Simpler, faster, but concentration risk if that lender exits
Club deal (2-4 lenders): Balance of simplicity and capacity
Syndicated (5+ lenders): Required for large facilities; more complex but diversified

Documentation standards: The Fund Finance Association has developed model documents. Using market-standard terms speeds execution. Custom terms require negotiation leverage (large fund, premier GP) and add legal cost.

Documentation and key terms

Subscription line documentation

Key documents:

Credit agreement. Loan terms, pricing, covenants, events of default
Security agreement. Pledge of right to call capital from LPs
Account control agreements. Cash management and sweep mechanics
LP verification letters. Confirm commitment amount and LP’s ability to fund

Critical negotiation points:

Issue	What to Push For
Borrowing base calculation	Clear methodology; fewer exclusions
LP eligibility	Broad inclusion; narrow default definitions
Concentration limits	Higher limits if you have anchor LPs
Cure rights	10-30 days to remedy borrowing base deficiency
Events of default	Narrow triggers; materiality thresholds

NAV facility documentation

Key documents:

Credit agreement. More complex than subscription lines given portfolio collateral
Pledge agreement. Security interest in portfolio company equity interests
Subordination agreements. Coordinate with portfolio company debt
Intercreditor agreements. If multiple fund-level lenders

Critical negotiation points:

Issue	What to Push For
Valuation methodology	GP marks with lender review (not lender marks)
Advance rate	Maximize based on portfolio quality
Eligible assets	Broad inclusion; fewer concentration penalties
NAV maintenance	Cushion you can maintain in downside case
Liquidation rights	Narrow and delayed; cure periods before forced sale

Structural considerations: Tax blockers for non-US LPs, offshore vehicles, and fund-of-funds structures all complicate NAV facility documentation. Build legal budget accordingly.

Hybrid facilities

Some managers use combination structures: a single facility with both subscription line and NAV components, sharing collateral across unfunded commitments and portfolio value.

When hybrids make sense:

Transitioning from investment period (sub line dominant) to harvesting (NAV dominant)
Maximizing total borrowing capacity
Single lender relationship simplicity

Trade-off: More complex documentation and collateral arrangements. Works best with relationship lender who understands the full picture.

LP perspective and due diligence

Pre-investment diligence

LPA review checklist:

Does the LPA permit subscription lines? NAV facilities? Both?
What size limits exist (percentage of commitments, percentage of NAV)?
What purpose restrictions apply?
What LP consent requirements exist?
What disclosure obligations does the GP accept?

Side letter provisions to request:

Enhanced disclosure on facility utilization (quarterly, not just annual)
IRR reporting both with and without subscription line adjustment
Notification of any facility in excess of stated limits
Right to see facility documentation upon request

Manager policy questions:

What is your stated policy on fund-level leverage?
How have you used facilities in prior funds? (Request historical data)
What is GP co-investment alongside LP exposure?
Have you ever had a covenant issue or margin call?

Ongoing monitoring

Quarterly reporting should include:

Current facility utilization (drawn vs. committed)
NAV cushion vs. borrowing base requirement
Interest expense as percentage of NAV
Purpose of recent draws

Red flags to watch:

Facility utilization increasing over time (are they becoming dependent?)
NAV cushion declining toward covenant minimums
Distributions funded by facility draws rather than asset realizations
Facility terms becoming more aggressive (higher leverage, longer tenor)

ILPA guidelines

The Institutional Limited Partners Association recommends:

Full disclosure of all fund-level facilities to LPs
IRR reporting both with and without subscription line impact
Clear explanation of facility purpose and actual use
LP notification of material facility changes

Questions every LP should ask:

What facilities do you have in place today? What’s the current utilization?
How do you calculate and report IRR?
What LPA limits exist on leverage?
Have you ever had a margin call or covenant issue?
How do you stress test your facility usage?

Risk management and stress scenarios

Subscription line stress scenarios

Scenario 1: LP default

Your largest LP (15% of commitments) fails to fund a capital call. Your borrowing base shrinks immediately. If you were at 90% advance rate, you’re now over-advanced.

Cure options: Call capital from other LPs to pay down facility. Negotiate a temporary waiver while you work out the LP situation. Find a secondary buyer for the defaulting LP’s interest.

Mitigation: LP concentration limits below 10%. Credit screening of LP base. Diversified LP roster.

Scenario 2: Bank withdrawal

Your bank exits fund finance (2023 saw several). Your facility is not renewed at maturity.

Cure options: Find alternative lender (competitive market helps). Call capital to pay down facility. Negotiate extension while arranging replacement.

Mitigation: Multi-bank syndicate from the start. Relationships with backup lenders. Conservative facility sizing that makes you attractive to replacement lenders.

Scenario 3: Broad market stress

LP liquidity concerns emerge across private markets (denominator effect). Banks tighten terms and reduce advance rates.

What happens: Facility refinancing at worse terms. Potential borrowing base deficiency if advance rates drop. Need to call capital or reduce borrowing.

2020 COVID stress test: Subscription line market held up well. Banks honored facilities. Some tightening on new deals but no systemic failure. This was reassuring but not guaranteed to repeat.

NAV facility stress scenarios

Scenario 1: NAV decline

Your portfolio marks down 40% in a market correction. Your 50% advance rate NAV facility is now underwater.

Cure options: Pay down facility from other sources. Inject equity (from GP or new LP capital). Negotiate forbearance while you work through the situation.

If not cured: Lender may have liquidation rights. Forced portfolio sales at distressed prices. Cascading value destruction.

Scenario 2: Liquidity crunch

Portfolio companies can’t be sold at acceptable values. Your NAV facility matures with no refinancing available.

What happens: Fund may become a forced seller. Assets sold at discounts to NAV. LPs face value destruction. GP reputation damaged.

Scenario 3: Cascading effects

NAV facility stress forces portfolio sales at 60 cents on the dollar. This triggers further NAV decline. Remaining facility becomes more underwater. More forced sales. A margin call spiral.

Most vulnerable: Concentrated portfolios. Illiquid assets. Funds with limited GP resources to inject capital.

Risk mitigation strategies

For fund managers:

Size conservatively. Don’t use maximum available leverage. Leave cushion.
Maintain NAV buffer. Stay well above covenant minimums.
Diversify lenders. Multi-bank facilities reduce single-point-of-failure risk.
Stress test actively. Model what happens if NAV drops 30%, 50%.
Communicate proactively. If you see trouble coming, talk to lenders early.

For LPs:

Understand total leverage. Ask for stress-tested projections.
Monitor covenant cushion. Quarterly reporting should show headroom.
Consider opt-out. Some LPAs allow opting out of highly leveraged structures.
Aggregate across portfolio. Your total fund-level leverage exposure may be higher than any single fund suggests.

Industry evolution

The fund finance market is evolving toward greater transparency:

ILPA best practices gaining adoption
Regulatory interest increasing (SEC, ESMA monitoring leverage in private funds)
LP pressure driving better disclosure
Standardization through Fund Finance Association improving market efficiency

Expect continued scrutiny. GPs who embrace transparency will differentiate positively. Those who resist will face harder questions.

Worked example: subscription line IRR impact

Setup:

$500M fund with 3-year investment period
SOFR + 200bps subscription line, 25% of commitments ($125M)
Fund makes $100M investment on Day 1 of Year 1

Without subscription line:

Event	Timing	Cash Flow
Capital call	Day 1	-$100M
Exit proceeds	Year 4	+$180M
IRR		15.8%

With subscription line:

Event	Timing	Cash Flow
Subscription line draw	Day 1	(no LP cash flow)
Capital call (repays sub line)	Month 9	-$100M
Interest cost borne by fund	Months 1-9	-$4.5M
Exit proceeds	Year 4	+$180M
Net exit to LPs	Year 4	+$175.5M
IRR		18.2%

Analysis:

The LP’s measured IRR is 240bps higher (18.2% vs. 15.8%). But:

The LP received $4.5M less ($175.5M vs. $180M) due to interest expense
The LP’s actual wealth creation was lower
TVPI fell from 1.80x to 1.76x

The subscription line made the IRR look better while making the actual return worse.

Worked example: NAV facility stress test

Setup:

$300M portfolio NAV
$120M NAV facility (40% of NAV)
Advance rate: 50%
NAV maintenance covenant: Must maintain 1.5x coverage (NAV / facility balance)

Current state:

NAV: $300M
Facility drawn: $120M
Coverage ratio: 2.5x (healthy cushion above 1.5x minimum)

Stress scenario: 35% NAV decline

NAV drops to: $195M
Facility balance: $120M (unchanged)
Coverage ratio: 1.625x (still above 1.5x, but barely)

Stress scenario: 45% NAV decline

NAV drops to: $165M
Facility balance: $120M
Coverage ratio: 1.375x (below 1.5x covenant)
Covenant breach triggered

Required cure:

To restore 1.5x coverage with NAV at $165M:

Maximum facility balance = $165M / 1.5 = $110M
Required paydown = $120M - $110M = $10M

If the fund cannot pay down $10M (from GP injection, LP capital call, or asset sale), the lender can exercise remedies including forced asset sales.

Lesson: A 40% advance rate NAV facility can survive 35% NAV decline but breaches covenants at 45% decline. Fund managers should stress test to understand their breaking points.

Cross-references

Back Leverage and Fund Financing for return calculations with leverage
Allocator Guide for LP due diligence framework
Bank Balance Sheet for bank provider considerations
Warehouse Facilities for comparison of asset-level vs. fund-level financing